Pharmacological treatment in the smoking cessation program in Brazil and the world
DOI:
https://doi.org/10.36489/saudecoletiva.2022v12i80p11420-11433Keywords:
Public Health, Tobacco Use, Pharmacological treatmentAbstract
Objective: to identify how the pharmacological treatment has been for people included in the National Tobacco Cessation Program (NTCP). Method: this is an integrative literature review of articles selected in the databases: Biblioteca Virtual em Saúde and Pubmed, from 2015 to 2020, in Portuguese, English and Spanish. The descriptors were used: Smoking and drug treatment. The selection was made through an adaptation of the PRISMA protocol, resulting in 7 articles that make up the review. Result: the association of varenicline with behavioral counseling and a gradual reduction in the number of cigarettes before smoking cessation increases smoking cessation rates. Other promising therapies such as Yoga, micronutrients and psilocybin still need further study. Conclusion: as a topic of great interest to public health, it is expected that the findings can improve the PNCT and instigate new Brazilian research on therapeutic management in smoking cessation groups.
References
World Health Organization. Report on the global tobacco epidemic [internet]. Geneva; 2019. Available from: https://www.who.int/publications/i/item/9789241516204
Brasil. Ministério da Saúde, Instituto Nacional de Câncer. Tratamento do tabagismo [internet]. 2020 [Cited 2021 Fev 21]. Available from: https://www.inca.gov.br/programa-nacional-de-controle-do-tabagismo/tratamento
Dantas DRG, Pinheiro AHB, Rossoni ALM, Prado LO, Barreira SN. Tratamento do tabagismo no Brasil, com bupropiona ou vareniclina: uma revisão sistemática. Revista Saúde e Ciência Online [Internet], 2016; [cited 2021 Fev 10]. 5 (1): 61-75. Available from: https://rsc.revistas.ufcg.edu.br/index.php/rsc/article/view/204/200
Ferraz L, Busato MA, Teo CRPA, Mattos T, Lieshout B. Tabagismo: motivos da cessação e da recaída na população de um nasf. Hygeia [Internet]. 2015 Jul [cited 2021 Jul 27];11(20):127-137. Available from: http://www.seer.ufu.br/index.php/hygeia/article/view/28339/16849
Silva LCC, Araújo AJ, Queiroz AMD, Sales MPU, Castellano MVCO. Smoking control: challenges and achievements. Jornal Brasileiro de Pneumologia [Internet] 2016 Ago [cited 2021 Mar 22]; 42 (4): 290-298. Available from: https://www.scielo.br/j/jbpneu/a/9ZRBLwC4JbRYGXb66krwjBC/abstract/?lang=en
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. [Internet] PLoS Med 2009 [cited 2021 july 26];6(7): Available from: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000097
Camargo VP, Quintana AM, Weissheimer TKS, Junges N, Martins BCM. Transplante Renal: Um Caminho Para a Vida ou um Passo Para a Morte? Rev. Cont. Saúde [Internet], 2011; 11(20):515-24. Available from: https://www.revistas.unijui.edu.br/index.php/contextoesaude/article/view/1572
Galvão CM. Níveis de evidência [editorial]. Acta paul. Enferm. [Internet]. 2006 [cited 2021 Jul 26] ;19(2):5. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-21002006000200001&lng=en&nrm=iso
Siahpush M, Shaikh RA, McCarthy M, Kessler AS, Tibbits M, Singh GK. Association between duration of use of pharmacotherapy and smoking cessation: findings from a national survey. Bmj Open. Jan [Internet] 2015 Jan [cited 2021 Mar 21], 5 (1). Available from: https://bmjopen.bmj.com/content/5/1/e006229
Chang PY, Lo PC, Chang HC, Hsueh KC, Tsai YW. Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort from Taiwan. Plos One [Internet], 2016 Nov [cited 2021 Mar 22]. v. 11, (11). Available from: https://pubmed.ncbi.nlm.nih.gov/27893843/
Nakamura M, Abe M, Ohkura M, Treadow J, Yu CR, Park PW. Efficacy of Varenicline for Cigarette Reduction Before Quitting in Japanese Smokers: A Subpopulation Analysis of the Reduce to Quit Trial. Clinical therapeutics [Internet] 2017 Apr [cited 2021 July 26];39(4):863-872. Available from: https://pubmed.ncbi.nlm.nih.gov/28365035/
Peña P, Zagolin M, Acuña M, Navarrete S, Bustamante P, Canals A. Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario. Rev. méd. Chile [Internet] 2016 Ago [Cited 2021 Mar 21]; 144(8): 965-971. Available from: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000800002&lng=es. http://dx.doi.org/10.4067/S0034-98872016000800002.
Walker NJ, van Woerden HC, Kiparoglou V, Yang Y, Robinson H, Croghan E. Gender difference and effect of pharmacotherapy: findings from a smoking cessation service. Bmc Public Health [Internet] 2016 Out [cited 2021 Jul 18]; 16 (1038). Available from: https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-3672-y
Johnson MW, Garcia-Romeu A, Griffiths RR. Long-term follow-up of psilocybin-facilitated smoking cessation [published correction appears in Am J Drug Alcohol Abuse. 2017 Jan;43(1):127]. Am J Drug Alcohol Abuse [Internet]. 2017 Jan [cited 2021 July 26];43(1):55-60. Available from: https://pubmed.ncbi.nlm.nih.gov/27441452/
Ebbert JO, Croghan IT, Hurt RT, Schroeder DR, Hays JT. Varenicline for Smoking Cessation in Light Smokers. Nicotine & Tobacco Research [Internet]. 2016 Out [cited 2021 Jul 26];18(10):2031-2035. Available from: https://pubmed.ncbi.nlm.nih.gov/27117285/.
Santos MDV, santos SV, Caccia-bava, MCGG. Prevalência de estratégias para cessação do uso do tabaco na Atenção Primária à Saúde: uma revisão integrativa. Ciênc. saúde coletiva [Internet] 2019 Fev [cited 2021 Jul 20] (2): 563-572, Available from <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232019000200563&lng=en&nrm=iso>.
BRASIL, Ministério da Saúde. Estratégias para o cuidado da pessoa com doença crônica: o cuidado da pessoa tabagista. Secretaria de Atenção à Saúde, Departamento de Atenção Básica. Brasília: 2015. (Cadernos de Atenção Básica, n. 40). [Cited 2021 fev 21]. Available from: http://189.28.128.100/dab/docs/portaldab/publicacoes/caderno_40.pdf
Leung MKW, Bai D, Yip BHK, Fong MY, Lai PMH, Lai P, Lai ISY, Lam ZHW, Leung ATF, To DKY, Wong MT, Wong TK, Chao DVK. Combined nicotine patch with gum versus nicotine patch alone in smoking cessation in Hong Kong primary care clinics: a randomised controlled trial. BMC Public Health [Internet]. 2019 Oct [cited 2021 July 26];19(1):1302. Available from: https://pubmed.ncbi.nlm.nih.gov/31619205/.
Carson-Chahhoud KV, Smith BJ, Peters MJ, Brinn MP, Ameer F, Singh K, Fitridge R, Koblar SA, Jannes J, Veale AJ, Goldsworthy S, Hnin K, Esterman AJ. Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial. Plos One [Internet] 2020 Apr [cited 2021 Mar 23];15(4). Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0231095
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. [Internet]. 2017 Mar [cited 2021 July 26];3(3). Available from: https://pubmed.ncbi.nlm.nih.gov/28361496/.
Reihana PK, Blampied NM, Rucklidge JJ. Novel Mineral–Vitamin Treatment for Reduction in Cigarette Smoking: A Fully Blinded Randomized Placebo-Controlled Trial. Nicotine & Tobacco Research [Internet] 2019 Nov [Cited 2021 Jul 23]; 21 (11): 1496–1505, https://doi.org/10.1093/ntr/nty168.
Bock, B. C., Dunsiger, S. I., Rosen, R. K., Thind, H., Jennings, E., Fava, et all. Yoga as a Complementary Therapy for Smoking Cessation: Results from BreathEasy, a Randomized Clinical Trial. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco [Internet]. November 2019 [cited 2021 Apr 19];21(11), 1517–1523. Available from: https://academic.oup.com/ntr/article-abstract/21/11/1517/5122859?redirectedFrom=fulltext
